Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 204 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$1.7B
Avg Funding
$68.0M
Cities
21

Export 204 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Dublin, Ireland
$5.6M
raised

Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

May 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$8.0M
raised

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bogotá, Colombia
$731K
raised

Blueberries Medical is a producer of medicinal cannabis products.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$9.6M
raised

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Kelowna, Canada
$1.6M
raised

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$8.0M
raised

Mustang Bio is a clinical-stage biopharmaceutical company .

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$287.5M
raised

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Berwyn, United States
$6.0M
raised

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlton South, Australia
$5.0M
raised

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Waltham, United States
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$1.6M
raised

PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cranbury, United States
$165.0M
raised

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Naarden, The Netherlands
$452.6M
raised

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Princeton, United States
$3.9M
raised

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$350.0M
raised

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$1.2M
raised

Lumito is a medical device and technology licensing company located in Lund, Skane County, Sweden.

Nov 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States
$3.1M
raised

BullFrog AI is a developer of an artificial intelligence platform intended to help companies in clinical development.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Gothenburg, Sweden
$19K
raised

Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico
$2.4M
raised

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$27.0M
raised

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Sep 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$500K
raised

Allied produces premium craft cannabinoid health products that support PTSI patients.

Aug 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$175.0M
raised

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Del Mar, United States
$30.0M
raised

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$100K
raised

Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 204 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

204 Pharmaceutical Post-IPO Equity Startups (November 2026) — Page 6 | VCBacked